I_PRP agree_VBP with_IN the_DT statement_NN ``_`` Successful_JJ people_NNS try_VBP new_JJ things_NNS and_CC take_VB risks_NNS rather_RB than_IN only_RB doing_VBG what_WP they_PRP already_RB know_VB how_WRB to_TO do_VB well_RB ._. ''_''
People_NNS always_RB try_VBP new_JJ things_NNS in_IN oneway_NN or_CC the_DT other_JJ to_TO make_VB their_PRP$ life_NN more_RBR affordable_JJ or_CC happier_JJR ._.
When_WRB a_DT person_NN tries_VBZ in_IN developing_VBG something_NN that_WDT would_MD make_VB life_NN of_IN society_NN ,_, he_PRP will_MD succed_VB in_IN doing_VBG so_RB because_IN he_PRP have_VBP invested_VBN considerable_JJ amount_NN of_IN time_NN and_CC risk_NN ._.
Once_RB succeded_VBN ,_, he_PRP looks_VBZ for_IN new_JJ things_NNS that_WDT are_VBP pausable_JJ for_IN many_JJ people_NNS ._.
He_PRP takes_VBZ this_DT as_IN a_DT spirit_NN or_CC challenge_NN ._.
He_PRP brainstrom_FW ideas_NNS ,_, put_VBD to_TO experiment_NN and_CC take_VB the_DT risks_NNS ._.
It_PRP is_VBZ a_DT desire_NN to_TO try_VB newthings_NNS with_IN risk_NN for_IN the_DT people_NNS who_WP were_VBD successful_JJ in_IN the_DT past_NN ._.
It_PRP makes_VBZ them_PRP fell_VBD happier_JJR and_CC drive_VB forward_RB ._.
I_PRP would_MD give_VB some_DT personal_JJ examples_NNS to_TO strongly_RB support_VB my_PRP$ above_IN statement_NN ._.
For_IN instance_NN ,_, when_WRB I_PRP was_VBD working_VBG on_IN reasearch_NN project_NN at_IN a_DT pharmaceutical_JJ company_NN back_RB in_IN my_PRP$ early_JJ childhood_NN ,_, I_PRP developed_VBD a_DT drug_NN for_IN cancer_NN that_WDT helped_VBD cure_VB many_JJ people_NNS ._.
I_PRP took_VBD the_DT risk_NN in_IN developing_VBG the_DT drug_NN knowing_VBG the_DT consequences_NNS that_WDT will_MD have_VB my_PRP$ life_NN ._.
This_DT successful_JJ incident_NN led_VBD me_PRP to_TO try_VB new_JJ things_NNS ._.
Development_NN of_IN instrument_NN that_WDT revolutionized_VBD the_DT lives_NNS of_IN people_NNS who_WP have_VBP Diabetes_NNP (_CD people_NNS who_WP can_MD not_RB regulate_VB bood_NN sugar_NN )_NN ._.
This_DT happened_VBD when_WRB I_PRP was_VBD with_IN Pfizer_NNP in_IN early_JJ 1984_CD ._.
At_IN times_NNS there_EX is_VBZ no_DT way_NN people_NNS can_MD analyse_VB their_PRP$ blood_NN sugar_NN level_NN without_IN going_VBG to_TO hospitals_NNS ._.
It_PRP was_VBD really_RB very_RB hard_JJ on_IN me_PRP to_TO develop_VB and_CC instrument_NN that_WDT would_MD one_CD day_NN help_NN everyone_NN to_TO get_VB their_PRP$ blood_NN glucose_NN results_VBZ instantaneously_RB ._.
I_PRP had_VBD spent_VBN considerable_JJ amount_NN of_IN time_NN on_IN this_DT project_NN ._.
If_IN I_PRP am_VBP right_RB ,_, it_PRP took_VBD me_PRP 10_CD years_NNS to_TO develop_VB this_DT instrument_NN ._.
I_PRP felt_VBD it_PRP is_VBZ like_IN taking_VBG the_DT risk_NN ,_, because_IN I_PRP may_MD succed_VBD at_IN the_DT end_NN or_CC may_MD be_VB not_RB ._.
I_PRP was_VBD very_RB successful_JJ in_IN doing_VBG so_RB ._.
Finally_RB ,_, I_PRP would_MD appreciate_VB the_DT people_NNS who_WP are_VBP successful_JJ and_CC try_VB new_JJ things_NNS ,_, eventhough_JJ knowing_VBG the_DT risks_NNS in_IN doing_VBG so_RB ._.
